Bob Ward

Experienced Board Director and Chair

Role
Board Member at Antidote Therapeutics, Inc
Location
Philadelphia, PA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Bob Ward

Experienced CEO in building Biotechnology companies to achieve successful value creation milestones, such as Initial Public Offering (IPO); first FDA approval; first product launch. Grew Radius Health from a small private clinical stage company to #1 performing IPO; approval and launch of TYMLOS; created Oncology pipeline with a diverse and innovative team culture. Brought Eloxx Pharmaceuticals “onshore” building out Boston/PA footprint; listing on NASDAQ; advancing Rare disease portfolio. Experienced Board Director for both US (RDUS, ONCS, ELOX) and European Headquartered Public Companies (AKTX); Served as Chair for both Audit and Governance Board Committees. Currently serving on OncoSec Immunotherapies Board of Directors and on two early stage private Biotechnology Companies.

Experience

  1. Board Member

    Antidote Therapeutics, Inc

    Nov 2017 — Present · Philadelphia, PA, US

    Antidote Therapeutics is a science-driven biopharmaceutical company developing novel nicotine-blocking therapies to treat diseases caused or worsened by nicotine.

Education

  • UC Santa Barbara

    Bachelor of Science - BS, Physiological Psychology/Psychobiology

  • New Jersey Institute of Technology

    Master's degree, Business Administration and Management, General

  • The Johns Hopkins University School of Medicine

    Master's degree, Immunology

  • UC Santa Barbara

    Bachelor of Arts - BA, Biology/Biological Sciences, General

Skills

  • Product Launch
  • Drug Discovery
  • Clinical Trials
  • Antibodies
  • Cross-Functional Team Leadership
  • Competitive Intelligence
  • Biologics
  • Lifesciences
  • Strategy
  • Pharmaceutical Sales
  • Life Sciences
  • Gastroenterology
  • Sales Effectiveness
  • Drug Development
  • Biopharmaceuticals
  • Clinical Development
  • Neuroscience
  • Pharmaceutical Industry
  • Fda
  • Global Marketing
  • Market Access
  • CRO
  • Commercialization
  • Technology Transfer
  • Infectious Diseases
  • Therapeutic Areas
  • Pharmacology
  • R&D
  • Leadership
  • Oncology
  • Strategic Alliances
  • Management
  • Biotechnology
  • Drug Delivery
  • Endocrinology
  • Immunology
  • Business Strategy

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Bob Ward — Board Member at Antidote Therapeutics, Inc in Philadelphia, PA, US | Unifers